Pfizer is teaming up with a Chinese biotech on a $10.5 billion cancer drug deal
Cris Tolomia
·
2026-05-29
·
via Quartz
The U.S. pharma giant will pay $650 million upfront to China's Innovent Biologics to co-develop 12 early-stag…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。